169 related articles for article (PubMed ID: 33728946)
1. Organ tropism in solid tumor metastasis: an updated review.
Mortezaee K
Future Oncol; 2021 May; 17(15):1943-1961. PubMed ID: 33728946
[TBL] [Abstract][Full Text] [Related]
2. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?
Stewart CL; Warner S; Ito K; Raoof M; Wu GX; Kessler J; Kim JY; Fong Y
Curr Probl Surg; 2018 Sep; 55(9):330-379. PubMed ID: 30526930
[TBL] [Abstract][Full Text] [Related]
3. Lung metastases share common immune features regardless of primary tumor origin.
García-Mulero S; Alonso MH; Pardo J; Santos C; Sanjuan X; Salazar R; Moreno V; Piulats JM; Sanz-Pamplona R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32591432
[TBL] [Abstract][Full Text] [Related]
4. Lung Metastasis Predicts Better Prognosis in Metastatic Colorectal Cancer With Mutated KRAS.
Margalit O; Shacham-Shmueli E; Lawrence YR; Yang YX; Reiss KA; Golan T; Mamtani R; Halpern N; Aderka D; Giantonio B; Boursi B
Clin Colorectal Cancer; 2019 Sep; 18(3):e300-e307. PubMed ID: 31324478
[TBL] [Abstract][Full Text] [Related]
5. The prognostic analysis of different metastatic patterns in extensive-stage small-cell lung cancer patients: a large population-based study.
Cai H; Wang H; Li Z; Lin J; Yu J
Future Oncol; 2018 Jun; 14(14):1397-1407. PubMed ID: 29359568
[TBL] [Abstract][Full Text] [Related]
6. Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical registry for advanced colorectal cancer.
Khattak MA; Martin HL; Beeke C; Price T; Carruthers S; Kim S; Padbury R; Karapetis CS
Clin Colorectal Cancer; 2012 Dec; 11(4):247-54. PubMed ID: 22763194
[TBL] [Abstract][Full Text] [Related]
7. Expression of Yes-associated protein (YAP) in metastatic breast cancer.
Kim HM; Jung WH; Koo JS
Int J Clin Exp Pathol; 2015; 8(9):11248-57. PubMed ID: 26617849
[TBL] [Abstract][Full Text] [Related]
8. Metastatic progression of breast cancer: insights from 50 years of autopsies.
Cummings MC; Simpson PT; Reid LE; Jayanthan J; Skerman J; Song S; McCart Reed AE; Kutasovic JR; Morey AL; Marquart L; O'Rourke P; Lakhani SR
J Pathol; 2014 Jan; 232(1):23-31. PubMed ID: 24122263
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer: Metastases to a single organ.
Vatandoust S; Price TJ; Karapetis CS
World J Gastroenterol; 2015 Nov; 21(41):11767-76. PubMed ID: 26557001
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
Gu Y; Wu G; Zou X; Huang P; Yi L
Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
[TBL] [Abstract][Full Text] [Related]
11. Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches.
Hebert JD; Myers SA; Naba A; Abbruzzese G; Lamar JM; Carr SA; Hynes RO
Cancer Res; 2020 Apr; 80(7):1475-1485. PubMed ID: 32019869
[TBL] [Abstract][Full Text] [Related]
12. Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse.
Harrell JC; Prat A; Parker JS; Fan C; He X; Carey L; Anders C; Ewend M; Perou CM
Breast Cancer Res Treat; 2012 Apr; 132(2):523-35. PubMed ID: 21671017
[TBL] [Abstract][Full Text] [Related]
13. A specific gene expression signature for visceral organ metastasis in breast cancer.
Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver.
Benedicto A; Romayor I; Arteta B
Oncol Rep; 2018 Apr; 39(4):2022-2030. PubMed ID: 29436696
[TBL] [Abstract][Full Text] [Related]
15. Separation of breast cancer and organ microenvironment transcriptomes in metastases.
Alzubi MA; Turner TH; Olex AL; Sohal SS; Tobin NP; Recio SG; Bergh J; Hatschek T; Parker JS; Sartorius CA; Perou CM; Dozmorov MG; Harrell JC
Breast Cancer Res; 2019 Mar; 21(1):36. PubMed ID: 30841919
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity accumulation in primary breast carcinomas and additionally in corresponding distant metastases is associated with poor outcome.
Hampl M; Hampl JA; Reiss G; Schackert G; Saeger HD; Schackert HK
Clin Cancer Res; 1999 Jun; 5(6):1417-25. PubMed ID: 10389927
[TBL] [Abstract][Full Text] [Related]
17. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
Press DJ; Miller ME; Liederbach E; Yao K; Huo D
Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366
[TBL] [Abstract][Full Text] [Related]
18. Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients.
Deng K; Yang C; Tan Q; Song W; Lu M; Zhao W; Lou G; Li Z; Li K; Hou Y
Gynecol Oncol; 2018 Sep; 150(3):460-465. PubMed ID: 30001833
[TBL] [Abstract][Full Text] [Related]
19. Improvement of survival and prospect of cure in patients with metastatic breast cancer.
Cheng YC; Ueno NT
Breast Cancer; 2012 Jul; 19(3):191-9. PubMed ID: 21567170
[TBL] [Abstract][Full Text] [Related]
20. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.
Yamamura J; Kamigaki S; Fujita J; Osato H; Manabe H; Tanaka Y; Shinzaki W; Hashimoto Y; Komoike Y
BMC Cancer; 2021 Apr; 21(1):476. PubMed ID: 33926418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
